Arnuity Ellipta is a Respiratory (inhalation) Powder in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Fluticasone Furoate.
Product ID | 0173-0888_3978a61b-f15c-42a7-94dc-0e77d6f2dcd4 |
NDC | 0173-0888 |
Product Type | Human Prescription Drug |
Proprietary Name | Arnuity Ellipta |
Generic Name | Fluticasone Furoate |
Dosage Form | Powder |
Route of Administration | RESPIRATORY (INHALATION) |
Marketing Start Date | 2018-05-17 |
Marketing Category | NDA / NDA |
Application Number | NDA205625 |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | FLUTICASONE FUROATE |
Active Ingredient Strength | 50 ug/1 |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-05-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA205625 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-05-17 |
Marketing Category | NDA |
Application Number | NDA205625 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-05-17 |
Ingredient | Strength |
---|---|
FLUTICASONE FUROATE | 50 ug/1 |
SPL SET ID: | 50f193ee-1691-486d-9370-a664df63695c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0173-0874 | Arnuity Ellipta | fluticasone furoate |
0173-0876 | Arnuity Ellipta | fluticasone furoate |
0173-0888 | Arnuity Ellipta | fluticasone furoate |
0135-0615 | FLONASE SENSIMIST | fluticasone furoate |
0135-0616 | FLONASE SENSIMIST | fluticasone furoate |
50090-5967 | FLONASE SENSIMIST | fluticasone furoate |
50090-6075 | FLONASE SENSIMIST | fluticasone furoate |
0173-0753 | VERAMYST | fluticasone furoate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ARNUITY ELLIPTA 86230290 4823045 Live/Registered |
Glaxo Group Limited 2014-03-24 |